Nippon Chemiphar Co., Ltd. (TYO:4539)
Japan · Delayed Price · Currency is JPY 1,611.00
-19.00 (-1.17%)
May 29, 2026, 10:53 AM JST
Nippon Chemiphar Market Cap
Nippon Chemiphar has a market cap or net worth of 5.81 billion as of May 29, 2026. Its market cap has increased by 9.96% in one year.
Market Cap
5.81B
Enterprise Value
17.05B
Revenue
33.09B
Ranking
n/a
PE Ratio
29.40
Stock Price
1,611.00
Market Cap Chart
Since January 14, 1992, Nippon Chemiphar's market cap has decreased from 34.36B to 5.81B, a decrease of -83.09%. That is a compound annual growth rate of -5.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.81B | 1.64% |
| Dec 30, 2025 | 5.72B | 4.27% |
| Dec 30, 2024 | 5.48B | -3.80% |
| Dec 29, 2023 | 5.70B | -4.67% |
| Dec 30, 2022 | 5.98B | -17.63% |
| Dec 30, 2021 | 7.26B | -8.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharma Foods International | 18.67B |
| Fuso Pharmaceutical Industries,Ltd. | 17.35B |
| Taiko Pharmaceutical | 12.86B |
| Wakamoto Pharmaceutical | 9.78B |
| Morishita Jintan | 8.86B |
| Solasia Pharma K.K. | 6.55B |
| WDB coco | 6.18B |
| Cyfuse Biomedical K.K. | 5.79B |